Antibody Response to SARS-CoV-2 mRNA Vaccines in Patients with Rheumatic Diseases in Japan: Interim Analysis of a Multicenter Cohort Study.

Yusuke KashiwadoYasutaka KimotoTakuya SawabeKensuke IrinoShota NakanoJunki HiuraQiaolei WangShotaro KawanoMasahiro AyanoHiroki MitomaNobuyuki OnoYojiro ArinobuHiroaki NiiroTaeko HottaDongchon KangKoichi AkashiShiro OhshimaTsutomu TakeuchiTakahiko Horiuchi

Published in: Modern rheumatology (2022)

Additional early vaccination is required in patients treated with TNFi and MTX, abatacept, MMF, MMF or MZR combined with CNI and CPA/RTX.

Keyphrases

sars cov
rheumatoid arthritis
respiratory syndrome coronavirus
rheumatoid arthritis patients
binding protein
double blind